Arschang Valipour (Otto-Wagner-Spital, Wien, Austria) discusses the background and findings of his late-breaking presentation entitled: First-in-Human Results of Bronchial Rheoplasty: An Endobronchial Treatment For Chronic Bronchitis (CB).
Questions1. What are the major unmet needs of patients with chronic bronchitis? (0:12)
2. What is the rationale for the ablation of mucus-producing airway cells in patients with chronic bronchitis? (0:48)
3. How is bronchial rheoplasty performed? (1:20)
4. Could you tell us a little about the first-in-human study you are presenting and its findings? (2:01)
5. Which patients are likely to benefit most from this procedure? (2:44)
Speaker disclosure: Arschang Valipour has nothing to disclose in relation to this video interview.
Filmed at the European Respiratory Society (ERS) International Congress 2018, Paris, France, September 2018.